Willis Towers Watson Public Limited Company Stock price
Equities
WTW
IE00BDB6Q211
Multiline Insurance & Brokers
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
242.6 USD | +0.46% | -1.50% | -0.81% |
Financials (USD)
Sales 2023 * | 9.45B | Sales 2024 * | 9.94B | Capitalization | 25.06B |
---|---|---|---|---|---|
Net income 2023 * | 1.09B | Net income 2024 * | 1.36B | EV / Sales 2023 * | 3,13x |
Net Debt 2023 * | 4.51B | Net Debt 2024 * | 4.73B | EV / Sales 2024 * | 3,00x |
P/E ratio 2023 * | 24,0x | P/E ratio 2024 * | 18,7x | Employees | 46,000 |
Yield 2023 * | 1,38% | Yield 2024 * | 1,37% | Free-Float | 99.57% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
1 day | +0.46% | ||
1 week | -1.50% | ||
Current month | -1.50% | ||
1 month | +2.59% | ||
3 months | +19.00% | ||
6 months | +8.06% | ||
Current year | -0.81% |
1 week
240.00
246.50

1 month
234.49
247.49

Current year
195.29
258.93

1 year
195.29
258.93

3 years
187.89
271.87

5 years
143.34
271.87

10 years
103.60
271.87

Managers | Title | Age | Since |
---|---|---|---|
Carl Hess
CEO | Chief Executive Officer | 60 | 1988 |
Andrew Krasner
DFI | Director of Finance/CFO | 48 | 2021 |
Alexis Faber
COO | Chief Operating Officer | 46 | 2021 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Thomas
CHM | Chairman | 66 | 2016 |
Carl Hess
CEO | Chief Executive Officer | 60 | 1988 |
Paul Reilly
BRD | Director/Board Member | 68 | 2022 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.37% | 23 M€ | +19.42% | ||
1.90% | 567 M€ | +9.57% | ||
1.79% | 9 M€ | +15.45% | - | |
1.77% | 164 M€ | +1.13% |
Date | Price | Change | Volume |
---|---|---|---|
23-12-07 | 242.72 | +0.51% | 301,429 |
23-12-06 | 241.5 | -0.61% | 385,795 |
23-12-05 | 242.97 | -0.42% | 394,637 |
23-12-04 | 244 | -0.57% | 475,044 |
23-12-01 | 245.41 | -0.36% | 620,261 |
Delayed Quote Nasdaq, December 07, 2023 at 03:59 pm EST
More quotes
Willis Towers Watson Public Limited Company is a world leader in consulting, insurance brokerage and risk management software development. Revenues break down by activity as follows:
- human capital and social benefits consulting services (35.6%): consulting services in the organization, skills assessment, management and optimization of social benefits, compensation of executives and employees, etc. ;
- development of enterprise risk management solutions and services (31.9%): risk analysis, assessment consulting, effective risk management and anticipation services, design and development of software solutions for risk management. The group is also developing an insurance brokerage activity;
- risk/return balance management consulting services (17.7%): for investors, insurers and reinsurers. Additionally, the group offers insurance and reinsurance consulting services, financial management services, financing and investment strategies, as well as actuarial studies and expertise in mergers and acquisitions, etc., while developing software solutions for modeling and analysis of risks and financial activities;
- management and operation of a platform for the exchange and outsourcing of group health insurance plans and medical benefits (14.7%): allowing employees and retirees to choose the health coverage that meets their needs;
- other (0.1%).
Revenue is distributed geographically as follows: Ireland (1.7%), the United States (49.7%), the United Kingdom (20.5%) and other (28.1%).
Calendar
2024-02-07
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
242.72USD
Average target price
248.65USD
Spread / Average Target
+2.44%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.81% | 25 063 M $ | |
+7.18% | 64 408 M $ | |
+27.85% | 52 045 M $ | |
+29.51% | 20 998 M $ | |
+39.76% | 7 132 M $ | |
+6.53% | 5 231 M $ | |
+3.66% | 4 104 M $ | |
+19.04% | 1 936 M $ | |
+109.35% | 1 788 M $ | |
-23.07% | 1 244 M $ |